Source: http://www.google.es/patents/US7852490
Timestamp: 2013-05-18 09:38:32
Document Index: 315894703

Matched Legal Cases: ['arts 12', 'arts 12', 'art 12', 'art 14', 'arts 12', 'arts 12', 'arts 12', 'arts 12', 'arts 12', 'art 410', 'art 410', 'art 410', 'art 410', 'art 410', 'art 410', 'Application No. 08171499', 'Application No. 08151021', 'Application No. 08171499', 'Application No. 08150964', 'Application No. 08151021', 'art, 2002']

Patente US7852490 - Implanting optical cavity structures - Google PatentesB�squeda Im�genes Maps Play YouTube Noticias Gmail Drive M�s » B�squeda avanzada de patentes | Historial web | Iniciar sesi�n B�squeda avanzada de patentesPatentesAn implantable product includes an optical cavity structure with first and second parts, each of which can operate as an optical cavity. The first part includes a container with at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product...http://www.google.es/patents/US7852490?utm_source=gb-gplus-sharePatente US7852490 - Implanting optical cavity structures N�mero de publicaci�nUS7852490 B2Tipo de publicaci�nConcesi�n N�mero de solicitud11/702,329 Fecha de publicaci�n14 Dic 2010 Fecha de presentaci�n5 Feb 2007 Fecha de prioridad5 Feb 2007Tambi�n publicado comoEP1953532A2EP1953532A3EP1953532B1US8040526US20080186483US20110082353 InventoresMichael BasslerRichard H. BruceNoble M. JohnsonPeter KieselOliver Schmidt Cesionario originalPalo Alto Research Center Incorporated Clasificaci�n de EE.UU.356/519 Clasificaci�n internacionalG01B9/02 Clasificaci�n cooperativaG01N21/31A61B5/0075G01N21/0303G01N21/274A61B5/1459A61B5/0084A61B5/14532G01N21/03 Clasificaci�n europeaG01N 21/27EG01N 21/03G01N 21/31G01N 21/03AA61B 5/145GA61B 5/1459ReferenciasCitas de patentes (83)Otras citas (50) Citada por (4)Enlaces externosUSPTO Cesi�n de USPTO EspacenetImplanting optical cavity structuresUS 7852490 B2 Resumen An implantable product includes an optical cavity structure with first and second parts, each of which can operate as an optical cavity. The first part includes a container with at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body. The second part includes a container that is closed and contains a reference fluid. The implantable product can also include one or both of a light source component and a photosensing component. Photosensed quantities from the first part's output light can be adjusted based on photosensed quantities from the second part's output light. Both parts can have their light interface surfaces aligned so that they both receive input light from a light source component and both provide output light to a photosensing component.
1. An implantable product comprising:
an optical cavity structure operating as an interferometer; the optical cavity structure including:
first and second optical cavity parts, each operable as a respective optical cavity and each including a respective light transmissive portion, and wherein light input to the first and second optical cavity parts is reflected more than once across the respective light transmissive portions; each of the first and second optical cavity parts including a respective container; the first part's container having at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body; the second part's container being closed and containing a reference fluid.
2. The implantable product of claim 1, further comprising:
a photosensing component connected to the optical cavity structure and positioned to receive light from both of the first and second optical cavity parts.
3. The implantable product of claim 2, further comprising:
circuitry that receives sensing results from the photosensing component and uses the sensing results to obtain information about bodily fluid in the first optical cavity part's container.
4. The implantable product of claim 3 in which the circuitry adjusts photosensed quantities from the first optical cavity part's output light based on photosensed quantities from the second optical cavity part's output light to obtain the information about the bodily fluid.
5. The implantable product of claim 1 in which the reference fluid is a glucose solution.
6. A system comprising the implantable product of claim 1, the system further comprising:
processing circuitry that adjusts photosensed quantities from the first optical cavity part's output light based on photosensed quantities from the second optical cavity part's output light to obtain information about the bodily fluid in the first optical cavity part's container.
a light source component that provides input light to both of the first and second optical cavity parts under control of the processing circuitry.
8. The system of claim 7 in which the processing circuitry controls the light source component to provide the input light so that each of the first and second optical cavity parts, when operating as an optical cavity, provides output light in a set of one or more modes.
a photosensing component that receives light from both of the first and second optical cavity parts and provides sensing results to the processing circuitry.
10. A method of making an implantable product, the method comprising:
making an optical cavity structure, operable as an interferometer, that includes first and second optical cavity parts, each operable as a respective optical cavity and each including a respective light transmissive portion, and wherein light input to the first and second optical cavity parts is reflected more than once across the respective light transmissive portions; the act of making the optical cavity comprising:
making each of the first and second optical cavity parts to include a respective container; the first part's container having at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body; the second part's container being closed and containing a reference fluid.
11. The method of claim 10 in which the act of making the optical cavity structure further comprises:
making first and second partial optical cavity structures; and
connecting the first and second partial optical cavity structures to form the optical cavity structure.
connecting a photosensing component to the optical cavity structure.
connecting a light source component to the optical cavity structure.
14. An implantable product comprising:
an optical cavity structure, operable as an interferometer; the optical cavity structure including:
first and second parts;
in each of the first and second parts, a respective container; the first part's container having at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body; the second part's container being closed and containing a reference fluid;
in each of the first and second parts, a respective light-transmissive region that includes at least part of the part's container;
in each of the first and second parts, a respective set of reflective surfaces that at least partially bound the respective light-transmissive region so that the part can operate as an optical cavity;
a first aligned light interface surface; when at least one of the first and second parts is operating as an optical cavity, the first aligned light interface surface doing at least one of:
receiving input light from a light source, the input light from the light source entering both of the first and second parts through the first aligned light interface surface; and
providing output light to a photosensing component, the output light being provided from both of the first and second parts through the first aligned light interface surface.
15. The implantable product of claim 14 in which each of the first and second parts operates as a Fabry-Perot cavity.
16. The implantable product of claim 14, further comprising:
a light source connected to the optical cavity structure and positioned to provide light to the first aligned light interface surface.
17. The implantable product of claim 14, further comprising:
a photosensing component connected to the optical cavity structure and positioned to receive output light from the first aligned light interface surface.
18. The implantable product of claim 17, further comprising:
circuitry that receives sensing results from the photosensing component and uses the sensing results to obtain information about bodily fluid in the sampling container.
19. The implantable product of claim 14 in which the optical cavity structure further includes:
a second aligned light interface surface; in use, the input light from the light source entering both of the first and second parts through the first aligned light interface surface and the output light from both of the first and second parts being provided through the second aligned light interface surface, and wherein the first aligned light interface surface is part of a first partial structure and wherein the first partial structure further includes a first light reflective component, and wherein the second aligned light interface is part of a second partial structure and wherein the second partial structure further includes a second light reflective component.
20. The implantable product of claim 14 in which the input light from the light source enters both of the first and second parts through the first aligned light interface surface and also the output light from both of the first and second parts is provided through the first aligned light interface surface.
21. The implantable product of claim 14 in which each of the first and second parts, when operating as an optical cavity, provides output light in a set of one or more modes.
22. The implantable product of claim 14 in which the first and second parts have first and second light interfaces, respectively; the first and second light interfaces both being in the first aligned light interface surface such that at least one of:
the input light is received similarly by both the first and second light interfaces; and
the output light is provided similarly from both the first and second light interfaces.
23. An implantable product comprising:
an optical cavity structure; the optical cavity structure including:
first and second light-transmissive structures separated by a light-transmissive region that includes first and second containers; in use, the first and second containers containing different fluids; and
a wall-like structure in the light-transmissive region between the first and second containers and bounding each of the first and second containers in part; at least one of the first and second containers having a set of one or more openings through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body;
each of the first and second light-transmissive structures including:
a respective reflective component bounding each of the first and second containers in part; each of the first and second containers, together with the respective reflective components that bound the container, being operable as a respective optical cavity in which interference occurs in one or more photon energy subranges, the optical cavity providing output light in one or more transmissive and/or reflective modes; the respective optical cavities of the first and second containers both having at least one mode that has a different intensity function as a result of the different fluids in the containers;
at least one of the first and second light-transmissive structures further including:
a respective light interface surface disposed away from the light-transmissive region, the light interface surface including, for each of the first and second containers, a respective light interface through which, in use, input light enters the container and/or output light is provided from the container; the light interfaces of the first and second containers both being in the light interface surface such that at least one of:
input light is received similarly by both the light interfaces of the first and second containers; and
output light is provided similarly from both the light interfaces of the first and second containers.
24. The implantable product of claim 23 in which each of the first and second containers, together with the respective reflective components, operates as a Fabry-Perot cavity.
25. The implantable product of claim 23 in which both of the first and second containers, together with the respective reflective components, operate as homogeneous optical cavities.
26. The implantable product of claim 23 in which both of the first and second containers, together with the respective reflective components, operate as inhomogeneous optical cavities.
27. The implantable product of claim 26 in which the first and second containers, together with the respective reflective components, are tunable.
28. The implantable product of claim 23, further comprising:
a light source connected to the optical cavity structure and positioned to provide light to both of the first and second containers.
29. The implantable product of claim 23 in which each of the first and second containers, when operating together with the respective reflective components as an optical cavity, provides output light in a set of one or more modes.
This application is related to the following co-pending applications, each of which is hereby incorporated by reference in its entirety: �Chip-Size Wavelength Detector�, U.S. patent application Ser. No. 10/922,870, now published as U.S. Patent Application Publication No. 2006/0039009; �Obtaining Analyte Information�, U.S. patent application Ser. No. 11/316,303; �Position-Based Response to Light�, U.S. patent application Ser. No. 11/633,302; �Photosensing Optical Cavity Output Light�, U.S. patent application Ser. No. 11/702,250; �Encoding Optical Cavity Output Light�, U.S. patent application Ser. No. 11/702,363; �Obtaining Information From Optical Cavity Output Light�, U.S. patent application Ser. No. 11/702,249; �Containing Analyte In Optical Cavity Structures�, U.S. patent application Ser. No. 11/702,325; �Tuning Optical Cavities�, U.S. patent application Ser. No. 11/702,321; and �Tuning Optical Cavities�, U.S. patent application Ser. No. 11/702,320.
BACKGROUND OF THE INVENTION The present invention relates generally to techniques involving implantation of products in bodies, such as products that that include optical components and can be used to obtain information, such as about analytes.
U.S. Pat. No. 6,216,022 describes an implantable optical measurement device or system that has an entry window, an exit window, a reference path between the windows, and a measurement path between the windows. The reference path includes a reference element with known optical characteristics, and the measurement path is in fluid communication with the body fluids of a person. A first optical signal is directed through the person's tissue, the entry window, the reference path, the exit window, and again the person's tissue to an external optical sensor, and a second optical signal is directed through the same tissue, the entry window, the measurement path, the exit window, and again the same tissue to the external optical sensor. The first optical signal can be used to compensate for absorption, scattering, and other optical effects of the tissue on the second optical signal.
It would be advantageous to have improved techniques for implantable products, including improved techniques for products that include optical components.
SUMMARY OF THE INVENTION The invention provides various exemplary embodiments, including products, systems, methods, apparatus, and devices. In general, the embodiments involve implantable products that include optical cavity structures.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic perspective diagram of a product that includes an optical cavity structure and that can be implanted in a body.
FIG. 2 is a schematic side view of a homogeneous optical cavity that could be used in the product of FIG. 1.
FIG. 4 is a schematic side view of a graded optical cavity that is an example of an inhomogeneous optical cavity that could be used in the product of FIG. 1.
FIG. 7 is a schematic diagram of an implementation of a system that can include an optical cavity structure as in the product of FIG. 1.
FIG. 9 is a schematic diagram of an implementation of a system as in FIGS. 7 and 8 that can monitor analyte in bodily fluid.
FIG. 10 is a flow diagram showing operations of the analyte information routine in FIG. 8 as it could be implemented in the system of FIG. 9.
FIG. 11 is a schematic diagram of components in an implementation of the system of FIG. 9 FIG. 12 is a schematic diagram of components in another implementation of the system of FIG. 9.
FIG. 13 is a schematic diagram of components in yet another implementation of the system of FIG. 9.
FIG. 14 is a schematic side view of a graded optical cavity that can contain analyte and reference fluid and could be used to implement an implantable product as in FIGS. 1, 9, and 11-13.
FIG. 15 is a schematic top view of a photosensing component as in FIG. 14.
FIG. 16 is a flowchart showing operations in producing and implanting products as in FIGS. 1, 9, and 11-14.
The various exemplary implementations described below address problems that arise in using light to obtain information, such as about analytes in bodily fluids. One problem is that accurate information may be difficult to obtain because of various types of noise that may be present when light passes through a body. Where a small implanted product is used, another problem is the difficulty of obtaining sufficient interaction between light and analyte. A further problem with such products is that frequent calibration is typically required, such as with a non-optical test; in the case of optical glucose sensing, for example, frequent calibration using the standard blood test method is typically required�there is currently no solution allowing for continuous around-the-clock glucose level monitoring without regular use of the standard blood test for recalibration, such as every couple of hours.
Although the exemplary implementations described below can be used to obtain information about analytes in human bodies, the term �body� is used herein to refer to any living body or a part of such a body that includes fluids, and can include non-human or even non-animal bodies. Fluids that occur in bodies are referred to as �bodily fluids�; common examples of human bodily fluids include blood, lymph, and interstitial fluids, but there are many others.
As used herein, �to implant� a thing in a body refers to any operation that begins with the thing outside the body and ends with the thing at least partially inside the body. An �implantable product� is therefore any article of manufacture capable of being implanted in a body.
The term �photon� refers herein to a quantum of light, and the term �photon energy� refers herein to the energy of a photon. Light can be described as having a �photon energy distribution�, meaning the combination of photon energies that are included in the light; highly monochromatic light, for example, has a photon energy distribution with one peak energy value. A photon energy distribution can be specified in space and time: For example, a photon energy distribution can be specified as a function of position, such as on a surface, or as a function of time; a photon energy distribution that is �homogeneous� is substantially the same at all relevant positions, such as the positions of a surface, while a photon energy distribution that is �stable� is substantially the same at all relevant times.
Propagating light can often be usefully characterized by direction and speed of propagation, with direction typically illustrated by one or more rays and with speed typically being described relative to the constant c, also referred to as the speed of light in vacuum. Where light changes direction in a way that can be illustrated as a vertex between an incoming ray and an outgoing ray, the change may be referred to as a �reflection�; similarly, to �reflect� light is to cause the light to change its direction of propagation approximately at a surface, referred to herein as a �reflection surface�. Where light propagates at less than c, it may be useful to obtain an �optical distance� of propagation; for any segment of length d in which speed of propagation is constant ε*c, where ε≦1, optical distance D(ε)=d/ε. An optical distance may be referred to herein as an �optical thickness�, such as where light is propagating through a thickness of material.
In an application of an IC that includes a photosensor array, circuitry that �responds to� one or more photosensors can be any circuitry that, in operation, receives information from the photosensors about their photosensing results through an electrical connection. Circuitry that responds to a photosensor could be circuitry in the same cell as the photosensor, or it could be array circuitry, peripheral circuitry, or other external circuitry, or it could include any suitable combination of cell circuitry, array circuitry, peripheral circuitry, and other external circuitry. Circuitry that responds to a photosensor could employ any suitable technique to readout photosensing results, including, for example, CCD, CMOS, or photodetector array (PDA) techniques.
FIG. 1 illustrates general features of product 10, an example of an implantable product that can be implemented as described in greater detail below. As with other implementations described below, product 10 involves a combination of parts or components. For example, product 10 includes parts 12 and 14, which could be referred to herein as first and second parts or as analyte and reference parts. In the illustrated implementation, parts 12 and 14 are connected along dashed line 16, which can be the result of being fabricated together. Product 10 is illustratively long and narrow, resembling a short needle, and FIG. 1 shows one end of product 10.
In the implementations described below, structures, systems, or parts or components of structures or systems may sometimes be referred to as �attached� to each other or to other structures, systems, parts, or components or visa versa, and operations are performed that �attach� structures, systems, or parts or components of structures or systems to each other or to other things or visa versa; the terms �attached�, �attach�, and related terms refer to any type of connecting that could be performed in the context. One type of attaching is �mounting�, which occurs when a first part or component is attached to a second part or component that functions as a support for the first. In contrast, the more generic term �connecting� includes not only �attaching� and �mounting�, but also making other types of connections such as electrical connections between or among devices or components of circuitry. A combination of one or more parts connected in any way is sometimes referred to herein as a �structure�.
Part 12 includes analyte container 20 and part 14 includes reference container 22. Containers 20 and 22 are separated by wall-like structure 24, and container 22 is fully enclosed, with wall-like structure 26 at its side opposite wall-like structure 24 and with each end closed by a similar wall-like structure, with wall-like structure 27 being visible. Container 20, on the other hand, is open, so that bodily fluid 28 can enter and exit, such as through an open end as shown or through openings (not shown) in side wall 29 opposite wall-like structure 24. In general, bodily fluid 28 can be continuously exchanged with surrounding regions to allow for continuous monitoring.
Parts 12 and 14 are each light transmissive, receiving input light through an entry surface as indicated by arrows 30 and providing output light through an exit surface as indicated by arrows 32. The designation of surfaces as entry and exit surfaces can, however, be somewhat arbitrary, and it may be possible in some implementations to reverse direction of input and output light, to have multiple entry or exit surfaces, or to both receive input light through and provide output light at the same surface; the term �light interface surface� is therefore used herein as a generic term that includes any of these types of entry and exit surfaces.
Partial structure 34, which can be implemented with glass or other light-transmissive material, includes light reflective component 36, while partial structure 40, also light-transmissive, similarly includes light reflective component 42. As a result, each of parts 12 and 14 has a respective optical cavity between light-reflective components 36 and 42. As suggested in FIG. 1, light interface surfaces of the first and second parts 12 and 14 are aligned so that they can receive input light from the same light source (not shown) and can similarly provide output light to the same photosensing component (not shown). This feature would be present whether photosensing output light from transmission modes or reflection modes. In general, light interactive surfaces are �aligned� in a given application with one or both of an external light source and an external photosensing component if they are in approximately the same plane or other surface such that input light from the application's external light source is received similarly on both surfaces and/or output light to the application's photosensing component is provided similarly from both surfaces.
A structure may be described by its operation, such as a �support structure� that can operate as a support as described above; similarly, an �optical cavity structure�, such as product 10, includes parts or components that can operate as an optical cavity; other examples are defined below. In addition, a structure may be characterized by the nature of its parts or the way in which they are connected; for example, a �layered structure� is a structure that includes one or more layers, and a �partial structure� refers to a structure that is in turn part of another structure.
Analyte is �present in�, �positioned in�, or simply �in� an optical cavity when the analyte is in all or some part of the cavity's light-transmissive region. An optical cavity provides �analyte-affected output light� if the optical cavity's output light is different in some way when analyte is present in the cavity than when analyte is absent, with the difference being due to the analyte's optical characteristics.
Box 50 at the ends of arrows 32 contains a graph, illustrating that the optical cavities of the first and second parts 12 and 14 each have a set of modes in which they provide output light, with intensity functions of three modes of reference cavity 22 being illustrated by solid-line curve 52 and those of counterpart modes of analyte container 20 being illustrated by dashed-line curve 54. The term �intensity function� refers to a function that relates intensity of output light to another parameter, such as photon energy for an �intensity-energy function� or, in some implementations, position of a light interface surface or a photosensitive surface.
An intensity function can have any of a wide variety of shapes and features, but a shape that frequently arises in transmission modes is the �peak�, a shape characterized by a maximum value from which a curve for the function slopes steeply downward. Peaks have various features, including �central value�, meaning the value of the other parameter at which the peak's maximum occurs, such as �central energy� for an intensity-energy function; �maximum intensity� or simply �maximum� or �amplitude�, meaning the intensity value at the peak's maximum, whether measured as an absolute intensity or relative to another feature, such as a nearby minimum value; �contrast�, meaning a value indicating relationship between magnitudes of the peak's maximum intensity and of one or more nearby minima of the transmission intensity function; and �intermediate intensity width�, meaning the width of the peak at an intensity somewhere between its maximum and nearby minima, such as a full width half maximum (FWHM). In general, information can be encoded in one of these features in various ways, including those described in co-pending U.S. patent application Ser. No. 11/702,363, entitled �Encoding Optical Cavity Output Light� and incorporated herein by reference in its entirety. Once encoded, such information can also be recovered in various ways, including those described in co-pending U.S. patent application Ser. No. 11/702,249, entitled �Obtaining Information From Optical Cavity Output Light� and incorporated herein by reference in its entirety.
In the illustrated example, the reference fluid in reference container 22 has optical characteristics that provide modes with relatively uniform intensity functions for the first, second, and third modes that are illustrated. Analyte in analyte container 20, however, has optical characteristics that cause changes in features of intensity functions of the modes, such as by changing central value, maximum intensity, or intermediate intensity width. Therefore, in curve 54, central values or energies of intensity functions for the first, second, and third modes are illustratively shifted from curve 52, such as by a change in refractive index; similarly, amplitudes and FWHMs of intensity functions of the second and third modes are changed from curve 52 to curve 54, such as by changes in absorption spectrum. Additional details about effects of refractive index and absorption and encoding techniques are provided in co-pending U.S. patent application Ser. No. 11/702,363, entitled �Encoding Optical Cavity Output Light� and incorporated herein by reference in its entirety.
As a result of these features, product 10 can be used in applications in which optical characteristics of a bodily fluid are compared with those of a reference fluid. Furthermore, as suggested by arrow 28, product 10 can be implanted within the body, allowing bodily fluid to enter and exit from container 20, such as from blood, lymph, or interstitial fluid, and continuous monitoring is possible if fluid is continuously exchanged in this manner.
The general features in FIG. 1 could be implemented in many ways, as exemplified by the various implementations described below. Parts of product 10 could be made of any of a wide variety of materials in various shapes and sizes and using a wide variety of different fabrication techniques. Further, connections between parts 12 and 14 and between other parts could be made in a wide variety of ways using various connecting techniques, including various deposition, coating, bonding, adhesive, or other connecting techniques.
FIG. 1 illustrates an example in which product 10 can be long and narrow, facilitating implantation, and insertion into a human body will also be easier if its transverse outer dimensions do not exceed approximately 0.5 mm. Current thin film fabrication technology can easily produce a structure of this size. Openings into the analyte container can be shaped, sized, and located for the required update time constant and other constraints of the application; for example, for monitoring a homogeneous fluid for glucose, it may be desirable for fluid to enter and exit freely in as many directions as possible, so that wall 29 in FIG. 1 may have many large openings along its length.
Product 10 could be implemented with a wide variety of types of optical cavity techniques. For example, it can operate as a homogeneous optical cavity, and its output light can pass through an LVF or other laterally varying transmission structure before being photosensed, such as by a photosensor array. This technique allows information to be obtained on the optical properties at multiple sampling points per readout. In this approach, product 10 could also be implemented with a tunable cavity, such as with deformable spacers, to set its wavelength range during manufacture or to adjust it during use, to provide a different set of sample points at each position. On the other hand, product 10 could operate as an inhomogeneous cavity illuminated, for example, by multiple narrow band light sources, either in an array or fired in sequence, so that photosensed readout provides sampling points, e.g. for a refractive index and absorption value, for each of the light sources. If implemented as an inhomogeneous cavity similar to an LVF connected to provide its output light to a photosensor array, product 10 can have a cavity thickness suitable to a given number of output light modes; for example, it could be sufficiently thin to transmit only a single mode at each position, in which case it could be illuminated by a broadband light source adjusted to its spectral range. In any case, product 10 could be used in a system that applies referencing techniques to reduce the effects of noise and inhomogeneities, especially adjustment of measurements from the analyte cavity based on measurements from the reference cavity, but also possibly including self-calibration and other types of referencing as mentioned below.
FIG. 3 is an intensity-energy graph or �output spectrum� for optical cavity 100 when operated as a Fabry-Perot cavity such as an interferometer. Since photon energy is inversely proportional to wavelength, wavelength increases as one moves leftward along the horizontal axis, while energy and frequency would increase to the right.
The graph in FIG. 3 includes a solid-line curve with peaks 130, 132, and 134, each of which is an �intensity-energy peak� or simply �intensity peak� that results from a respective transmission mode of cavity 100, illustratively the Kth, (K−1)th, and (K−2)th modes, and has an amplitude Imax, which could result from broadband illumination in the photon energy subranges of all the modes shown; such a curve is sometimes referred to herein as a �transmission spectrum�. FIG. 3 also includes part of dashed-line curve 136 that is the complement of the transmission spectrum, i.e. the intensity-energy curve for light that is reflected rather than transmitted by optical cavity 100; such a curve is sometimes referred to herein as a �reflection spectrum� and its reflection modes are broad and separated by narrow valleys rather than being narrow peaks separated by broad valleys like the transmission modes. The term �output modes� is sometimes used herein as a generic term that encompasses transmission modes and reflection modes.
Because of its linearly varying optical distance or thickness, cavity 150 can operate as a linearly variable optical filter (LVF), a type of transmissive cavity. This capability is illustrated by the function T(x), a �laterally varying energy output function� that relates output photon energy (in response to input light represented by illumination arrows 124) to lateral position on exit surface 120. For an LVF, the simple relationship λ(x)=T(x)=d′x+(0) can hold, where d′ is a constant that depends on gradient of optical thickness and can be graphically represented by the constant slope (λ(X2)−λ(X1))/(X2−X1)) of position-wavelength graph 154 at right in FIG. 4.
Various techniques can be used to produce laterally varying energy distributions with inhomogeneous optical cavities having laterally varying optical thicknesses and, even with homogeneous optical cavities, with angled illumination from a point light source rather than perpendicular illumination; several techniques are described in co-pending U.S. patent application Ser. No. 11/316,438, entitled �Photosensing Throughout Energy Range and in Subranges� and incorporated herein by reference in its entirety. More generally, an inhomogeneous optical cavity can have any appropriate laterally varying energy output function, including functions that are nonlinear or nonuniform in other ways. Some of the below-described implementations, for example, involve functions that are affected by presence of an analyte in an optical cavity. As with homogeneous cavities, an inhomogeneous cavity's light-transmissive region can be completely between and partially bounded by light-reflective components as in FIG. 4, but partially and completely bounded light-transmissive regions with various other shapes and arrangements are possible.
In the example of FIG. 5, transmission modes are sufficiently separated along the x-axis to prevent interference between adjacent transmission modes. As can be seen, Xmin(2) is sufficiently greater than Xmax(1) that peaks 172 and 174 do not interfere, and Xmin(3) is similarly sufficiently greater than Xmax(2) that peaks 176 and 178 do not interfere. If instead the first transmission mode of λmax were peak 180 due to an increase from Xmax(1) to Xmax(error), as indicated by arrow 182, interference between peaks 180 and 174 would begin to occur; as the first transmission mode of λmax increased further, loss of information would occur due to ambiguity between peak 180 and peak 174. Problems of this type can be avoided by coordination of photon energy range with cavity parameters; for example, cavity thickness D can be sufficiently small that only one output mode occurs over the range from λmin to λmax. The free spatial range (FSR) between the modes of a particular wavelength can also be increased by reducing the tilt of the inhomogeneous (graded) cavity.
FIG. 6 shows a setup in which optical cavity structure 190 receives input light represented by arrows 194 through beam splitter 192. Optical cavity structure 190 can include a transmissive cavity implemented as in any of the ways described in relation to FIGS. 2-5 or in any other suitable way. In response to the input light, the cavity provides a transmitted portion of output light represented by arrows 196 and a reflected portion of output light represented by arrows 198. The use of beam splitter 192 is merely illustrative of ways in which input light and reflected light could be separated; for example, input light could be incident upon an entry surface at a sufficiently large angle from the normal that reflected light is separated from input light, though the non-perpendicular angle of incidence reduces performance of the optical cavity.
FIG. 7 shows system 200, an exemplary implementation of a system that can include an optical cavity structure as in the product of FIG. 1. As used herein, a �system� is a combination of two or more parts or components that can perform an operation together. A system may be characterized by its operation: for example, an �analyte information system� is a system that operates somehow on analyte information; a �processing system� is a system that performs data or signal processing; and so forth.
Within a system, components and parts may be referred to in a similar manner. One component of an analyte information system in which information is obtained about an analyte's optical characteristics, for example, can be a �detector component� or simply �detector�, meaning a component that detects light; similarly, a �light source component� includes one or more light sources; an �optical component� performs an optical operation; a �photosensing component� performs a photosensing operation; an �information obtaining component� obtains information, such as from photosensing results; an �adjusting component� performs an adjusting operation, such as on photosensing results; a �light source component� includes one or more light sources; a �light-transmissive component� or simply �transmission component� transmits light; a �light-reflective component� or simply �reflective component� reflects light; and other examples are defined further below. Other parts or components can be characterized by their structure.
System 200 includes optical cavity structure 202, a structure that can include one or more optical cavities with features described above. In system 200, at least one of the optical cavities in structure 202, represented schematically by cavity 204, can contain an analyte, illustratively being provided to cavity 204. The presence of analyte in cavity 204 affects the output light provided by structure 202, and the analyte-affected output light, represented by arrow 206, can then be photosensed within detector 210. For example, detector 210 may include a photosensing component with one or more photosensitive surfaces at which lateral variation of light is detected, such as after the light passes through an LVF. The sensing results from detector 210 can be provided to other components within system 200 or to external components, as represented by arrow 212.
Although cavity 204 can be any suitable type of optical cavity, including an emitting cavity or a transmissive cavity, FIG. 7 illustratively shows one or more light sources 220 that can be included within system 200 to illuminate one or more optical cavities. As represented by arrow 222, structure 202 receives input light from light sources 220. If optical cavity 204 is illuminated as shown, the analyte-affected output light represented by arrow 206 could include one or both of transmitted and reflected light.
In the illustrated implementation of system 200, IC I/O 248 is a similar I/O component that permits CPU 240 to communicate with one or more ICs, such as in detector 210 in FIG. 5. M ICs are illustrated by a series from IC(0) 260 to IC(M-1) 262, including IC(m) 264 with a photosensor array 266.
FIG. 9 illustrates application of a system as described above in relation to FIGS. 7 and 8 in which optical cavity structure 202 (FIG. 7) is included in an implantable product with features as described above in relation to FIG. 1, in which case cavity control 252 (FIG. 8) would typically be unnecessary. System 300 illustratively includes optical cavity component 302, light source component 304, and detector component 306, with the implantable product including at least optical cavity component 302, possibly in combination with one or more other components, as described below. Optical cavity component 302 could be an implementation of implantable product 10 in FIG. 1, with the cross section of FIG. 9 taken at a point along the length of product 10 at which wall 29 (FIG. 1) has an opening through which bodily fluid can transfer between the interior and exterior of analyte container 20; in general, an analyte container in an implantable product can be implemented with any suitable combination of one or more such openings, including openings at each end as shown in FIG. 1 and any appropriate number of openings along its length as shown in FIG. 9.
During operation, one or more of the illustrated components of system 300 would be controlled by a processor such as CPU 240 (FIG. 8). In a typical implementation, fluid pressure inside the body could cause movement of bodily fluid containing analyte into an analyte cavity, as indicated by arrow 308, but if power is available in the implantable product for other operations as described below, electrochemical or electromechanical transport processes could also be implemented to manipulate bodily fluid within the analyte cavity, such as to assure representative sampling or to extend the operational life of the implantable product, and such processes could also be controlled by a processor. Power could be available in many possible ways, including, for example, from one or more batteries or, more elegantly and compactly, from one or more photocells or other electromagnetic receivers; an example would be a laser photocell operating with a 630 nm laser diode. The opening into region 322 could be covered, such as by a selective membrane, to allow only certain sizes of analytes to enter and exit.
In operation, optical cavity component 302 receives input light from light source component 304 and, in turn, provides its output light to detector component 306. In the illustrated example, optical cavity component 302 is shown in cross-sectional view, showing how light-reflective components 310 and 312 and wall structures 314 and 316 define two regions between light-reflective components 310 and 312. Region 320, bounded by reflective surfaces of components 310 and 312 and also by surfaces of structures 314 and 316, can contain a reference fluid, while region 322, also bounded by reflective surfaces of components 310 and 312 and also by a surface of structure 316 but open at a side opposite structure 316, can contain fluid that enters as indicated by arrow 308.
In operation, analyte-carrying fluid, such as interstitial fluid from between the cells of a human or other body, can enter region 322 through any appropriate physical process; the analyte can be glucose, for example. As a result, optical cavity component 302 in effect operates as two parallel optical cavities: One optical cavity includes region 320 and provides output light, represented by arrow 330, with information about optical characteristics of the reference fluid; the other optical cavity includes region 322 and provides output light, represented by arrow 332, with information about the analyte. Detector 306 obtains sensing results that include both types of information and the sensing results can be provided to an external component such as a CPU or other processor, as indicated by arrow 334.
FIG. 10 illustrates one example of how analyte information routine 274 (FIG. 8) could be implemented in a system like system 300 in FIG. 9. The routine in FIG. 10 follows a general strategy of iteratively performing a series of one or more illuminate-and-readout operations, each sampling optical characteristics at a discrete sampling point on the photon energy spectrum, until sufficient information about both analyte and reference fluid is obtained, after which reference-adjusted analyte information can be combined and provided. It would also be possible to provide reference-adjusted analyte information after each illuminate-and-readout operation or to provide information both immediately after each illuminate-and-readout operation and also after a series of illuminate-and-readout operations. In either case, the discrete sampling approach is especially suited to a principal component-like analysis.
The operation in box 350 begins each iteration by adjusting the illumination to be provided during the iteration. In this operation, CPU 240 can determine the appropriate illumination for the iteration and can then provide signals to light source 304, such as through illumination control 250 (FIG. 8) to obtain the appropriate illumination.
The operation in box 352 then provides illumination in accordance with the adjustment in box 350 and, concurrently, performs sensing readout during an appropriate sensing period or series of sensing periods. The sensing results obtained from the sensing readout include information from the modes of the output light from both the reference and analyte optical cavities in optical cavity component 302; this information can be encoded, for example, in the ways described above in relation to FIGS. 1, 3, and 5. During this operation, CPU 240 may also provide signals to peripheral circuitry on an IC so that analog quantities photosensed by cells are identified as resulting either from the analyte optical cavity or the reference optical cavity and so that the analog quantities from the analyte are adjusted based on those from the reference. After adjustment, if any, analog quantities can be converted to digital signals for readout. The operation in box 352 can be implemented in whatever manner is appropriate for a given photosensing IC, whether a CCD or CMOS implementation, and regardless of whether readout is purely serial or is also parallel.
If, as described above in relation to FIGS. 1, 3, and 5, information about analyte is encoded in intensity functions of one or more modes, this information can be included in sensing results in various ways. For example, detector component 306 can include a laterally varying transmission structure, so that each mode's reference and analog intensity-energy peaks have respective light spots on a photosensing IC in detector component 306. Therefore, the sensing results can include information about one or both of position, size, and intensity of each light spot and, accordingly, about the respective mode's intensity peaks. If output light from each cavity includes intensity peaks for two or more modes, their respective light spots could be tracked as described in co-pending U.S. patent application Ser. No. 11/702,249, entitled �Obtaining Information From Optical Cavity Output Light� and incorporated herein by reference in its entirety.
The photosensed quantities read out in box 352 can also be digitally adjusted by CPU 240. In other words, information about the reference fluid can be obtained by CPU 240 from the digitized output and can then be used to adjust digitized values obtained for the analyte. For example, the operation in box 352 or a subsequent operation can, for example, make a data manipulation or adjustment to obtain �cavity-only absorption data�, an expression that refers herein to values or other data in which information about absorption in an optical cavity is preserved while information is reduced about features exterior to the cavity such as inhomogeneities in illumination and external absorption, as described in co-pending U.S. patent application Ser. No. 11/702,249, entitled �Obtaining Information From Optical Cavity Output Light� and incorporated herein by reference in its entirety. As will be understood, the encoding of absorption information in this manner allows removal of noise-like effects other than those from absorption coefficient inside the optical cavity, influences such as external perturbations, disturbances, or inhomogeneities. As a result, measurements of absorption can have a higher signal to noise ratio. Also, information can be recovered from analyte-encoded output light that is selectively sensitive to absorption changes inside the cavity.
If cavity-only absorption data, such as contrast values, are obtained both for the analyte and the reference fluid, the analyte's values can be adjusted using the reference fluid's values, such as by taking a difference; this is one example of �self-calibration� as that term is used herein. Self-calibration can be especially useful in removing noise-like effects that arise if light source 304 and/or detector 306 are spaced apart from optical cavity component 302, as would be the case for some of the implementations described below. Where input or output light must pass through bodily tissue and fluids, measurements of absorption are subject to noise, but self-calibration can produce a higher signal to noise ratio.
The operation in box 352 can also include other operations. For example, digital adjustment in box 352 can also include any necessary adjustments due to differences in sensing periods or other factors.
With the results from box 352, the operation in box 354 then branches based on whether sufficient information has been obtained in accordance with any appropriate criterion, such as a number of iterations or a minimum set of illuminations. If the criterion is not met, a further iteration is performed, beginning with box 350 as described above. But if sufficient information has been obtained, CPU 240 can perform the operation in box 356 to provide reference-adjusted analyte information, such as in the form of data for another routine or as output through external I/O 249. As shown, this operation can include combining photosensed quantities obtained in box 352, and can also include any additional adjustments, including reference-based adjustments, that were not performed in box 352. The operation in box 356 can also included further processing, such as to obtain derivates of an absorption spectrum, which is especially useful in regard to glucose.
In performing the operations in boxes 352 and 356, CPU 240 can employ data structures (not shown) stored in memory 246 (FIG. 8). For example, the reference-adjusted analyte information from each iteration could be stored together with previously obtained information in a readout data structure. The operation in box 352 could update the readout data structure before completing each iteration, and then the readout data structure could be provided as output in box 356. If, for example, the operation in box 352 obtains absorption values for the analyte, the readout data structure could provide an absorption spectrum; similarly, refractive index dispersion could be obtained and provided.
The technique in FIG. 10 can also be combined with other types of measurements, such as Raman spectroscopy, intrinsic fluorescence spectroscopy and measurement of fluorescence lifetime, polarimetry to obtain rotation, and so forth, which could be performed using the same implantable product with additional iterations similar to those described above; combining absorption spectrum measurement with orthogonal methods such as polarimetry can improve sensitivity and specificity. The operation in box 356 can be extended to perform multiple signal analysis, and might obtain information about presence of a specific analyte such as glucose.
FIGS. 11-15 illustrate features of several exemplary implementations of system 300 (FIG. 9). In general, however, system 300 could be implemented in many different ways, and can include various implantable products that include optical cavity structures of various kinds, various types and combinations of light sources, and various types of detectors in addition to the examples described below.
FIG. 11 illustrates a configuration in which implantable product 400 includes neither light source component 304 nor detector component 306, but does include analyte optical cavity 402 and reference optical cavity 404. As shown, product 400 has been implanted in body part 410, which could be human dermis, and can be illuminated by light source component 304 on or near an exterior surface of body part 410, providing input light represented by arrows 412. In response to appropriate illumination, optical cavities 402 and 404 operate to provide output light represented by arrows 414. Detector component 306, also on or near an exterior surface of body part 410, photosenses the output light, providing sensing results as described above.
The configuration in FIG. 11 may be especially appropriate if input and output light are in the wavelength ranges 600-1100 nm or 2.1-2.5 μm, in which absorption by water and tissue allows a transmission window in which it may be possible to measure absorption of certain important analytes such as glucose. If implemented as a completely passive optical unit, product 400 may not require any electrical power. The configuration in FIG. 11 may, however, involve issues of orientation of components to ensure that illumination and detection are efficiently performed.
Orientation of components can result in non-perpendicular incidence of input light on optical cavities. Unless all output light is incident on one position of the detector component or the detector component has only a single large area as with some PSDs, adjustments can be made to correct for non-perpendicular incidence of input light: For example, if the light source component emits light from a point source at many different angles that are accordingly transmitted through the cavities at various angles, the detector component's photosensitive surface receives the output light at many different angles, but each cell of a photosensor array would receive only a very small angular distribution; therefore, if the angle could be known, as would be the case in a fixed geometry but may not be the case in FIG. 11, the angle-induced variation can be easily corrected.
FIG. 12 illustrates a configuration in which implantable product 430 does not include light source component 304, but does include analyte optical cavity 432, reference optical cavity 434 and detector component 436. As shown, product 430 has again been implanted in body part 410, and, as in FIG. 11, can be illuminated by light source component 304 on or near an exterior surface of body part 410, providing input light represented by arrows 440. In response to appropriate illumination, optical cavities 432 and 434 operate to provide output light to detector component 436, connected to optical cavities 432 and 434 in any appropriate way. Detector component 436 photosenses the output light and provides sensing results, such as by transmitting electromagnetic or other signals represented by arrow 442.
The configuration in FIG. 12 may also be appropriate if input and output light are in the wavelength ranges 600-1100 nm or 2.1-2.5 μm, for the same reasons as FIG. 11. In this configuration, product 430 must have an electrical power source for detector component 436. It may also involve issues of orientation of components to ensure that illumination is efficiently performed. If the measurements are referenced to a reference medium many of the issues with regard to the misalignment of the components can be corrected, since analyte and reference measurement are affected in the same manner.
FIG. 13 illustrates a configuration in which implantable product 460 includes analyte optical cavity 462, reference optical ,cavity 464, detector component 466, and light source component 468. As shown, product 460 has again been implanted in body part 410, but does not require illumination from outside the body as in FIGS. 11 and 12. Instead, light source component 468, connected to optical cavities 462 and 464 in any appropriate way, can illuminate cavities 462 and 464 in response to receiving electromagnetic or other control signals represented by arrow 470. In response to appropriate illumination, optical cavities 462 and 464 operate to provide output light to detector component 466, connected to optical cavities 462 and 464 in any appropriate way. As in FIG. 12, detector component 466 photosenses the output light and provides sensing results, such as by transmitting electromagnetic or other signals represented by arrow 472.
The configuration in FIG. 13 similarly must have an electrical power source for both light source component 468 and detector component 466. It may also involve issues of orientation of components to ensure that illumination is efficiently performed, although these issues are greatly reduced in this case since all components can be fixed relative to each other.
FIG. 14 shows device 500, variations of which can also be used to implement implantable products 400, 430, and 460 in FIGS. 11-13. As shown, device 500 can include an LVF-like inhomogeneous optical cavity, which could be illuminated during operation in any appropriate way, including with multiple narrow band light sources. The cavity could be part of a structure that also includes a photosensing component that photosenses its output light, such as in the ways described in co-pending U.S. patent application Ser. No. 11/702,325, entitled �Containing Analyte In Optical Cavity Structures� and incorporated herein by reference in its entirety. Device 500 can also be implemented with a tunable optical cavity, as described in co-pending U.S. patent application Ser. No. 11/702,321, entitled �Tuning Optical Cavities� and incorporated by reference herein in its entirety.
Light-reflective components 502 and 504 provide reflection surfaces on either side of region 506, which can include two containers, one containing analyte-containing fluid and the other reference fluid, as shown. As a result, when input light, represented by arrows 508, is received through component 502, inhomogeneous optical cavity operation as described in relation to FIGS. 4 and 5 can occur separately for each container, resulting in transmission of output light in one or more modes of each optical cavity to photosensing component 510. The indices of refraction of analyte and reference fluid in their respective parts of region 506 and the positioning of structures 502 and 504 determine positions of light transmission, and illumination in a single narrow wavelength band can be provided so that only one wavelength is transmitted from each optical cavity but at different output light positions for the two cavities due to their different optical characteristics, as suggested by arrows 512 FIG. 15 shows an example of the pattern of light on the upper surface of photosensing component 510 if the optical cavities were both illuminated in only one narrow wavelength band. As shown, light spot 514 on the analyte cavity side of photosensing component 510 indicates that the incident narrow band light is transmitted at a certain position XtransA from the analyte cavity, but the same narrow band is transmitted from the reference cavity at a different position in the x-direction, displaced from XtransA either toward Xmin (as shown by light spot 516 on the reference cavity side of photosensing component 510 at XtransR) or toward Xmax, depending on the difference between refractive indices of analyte and reference fluids. If analyte absorption changes, causing a change in intensity, contrast, and FWHM of output light's intensity function from the analyte container, the size and intensity of light spot 514 would change relative to light spot 516. In this way, the difference in the intensity functions of the two light spots provides information about the refractive index and absorption of the analyte.
Inhomogeneous optical cavities that contain analyte and reference fluid can be implemented in many ways in addition to the way illustrated in FIGS. 14 and 15. Additional techniques are described in co-pending U.S. patent application Ser. No. 11/702,325, entitled �Containing Analyte In Optical Cavity Structures� and incorporated herein by reference in its entirety.
FIG. 16 illustrates exemplary operations in producing products like implantable products 400, 430, and 460 in FIGS. 11-13. In particular, the operations in FIG. 16 make it possible to produce implantable products that include analyte and reference containers, each of which is within a respective optical cavity that can be operated to provide output light in one or more modes with information about optical characteristics of analyte and reference fluid.
The operation in box 600 in FIG. 16 produces two partial optical cavity structures. This operation can include producing a light reflective structure on each of two substrates, similar to light reflective structures 36 and 42 in FIG. 1. This operation can also include producing a patterned layer of SU-8 or polydimethylsiloxane (PDMS) on one or both of the light-reflective structures, such as with techniques described in co-pending U.S. patent application Ser. No. 11/315,992, entitled �Sensing Photons from Objects in Channels� and incorporated herein by reference in its entirety. Each patterned layer could include structures such as wall-like structures 24 and 26 in FIG. 1 and wall structures 314 and 316 in FIG. 9, together with other wall-like structures that enclose the reference container and partially enclose the analyte container.
If appropriate, an anti-adhesive coating can be applied to surfaces of the two containers, such as by dip-coating polyethylene glycol (PEG) or by providing a coating of parylene C or vapor deposit tetraglyme; these measures may be helpful in extending the operating life of an implantable product, by preventing clogging. Similarly, the product can include an input filter of a suitable kind in the opening into the analyte container, to minimize background.
The two partial structures can also have appropriate dimensions to satisfy various constraints. For example, for a compact, minimally invasive, disposable product, small dimensions are required. The volume of the resulting analyte cavity, for example, could be as small as a few 100 pl; even with a very small volume, adequate light-analyte interaction can occur in an optical cavity if reflectivity of reflection surfaces is sufficiently high. At the same time, dimensions must be chosen that can produce the desired optical cavity modes over the desired range of photon energies with the available illumination, such as to obtain an absorption spectrum or to measure refractive index dispersion; for example, the number of modes depends on the distance between reflection surfaces bounding the cavity. For implementation with an inhomogeneous cavity the following has to be considered: In these cases �multiple narrow band light sources� are used to define the absorption sampling points not the cavity thickness as in the homogeneous cavity cases. Each light source allows determining one refractive and one absorption value. Therefore for implementation with inhomogeneous cavities, a thin cavity thickness can be chosen, which also allows also for operation in spectral regions with higher background absorption. In an example for glucose monitoring, it might be desirable to use the spectral region between 7 and 11 μm in which glucose shows very characteristic glucose absorption peaks but unfortunately also the water background absorption is much higher than in other interesting spectral regions. For example, in the spectral region around 2.2 μm, the water absorption is lower by about a factor of 200, but glucose has a much lower and less specific absorption.
The operation in box 602 then attaches the two partial structures, with reference fluid in the reference container. This could be implemented in many different ways, including, for example, filling the reference container before attaching the partial structures or, alternatively, attaching the partial structures and then inserting fluid into the reference container, such as through a needle, after which an appropriate operation could be performed to ensure the reference container is sealed. The reference fluid can be any appropriate fluid; for glucose, for example, it could be a reference glucose concentration. The operation in box 602 can include forming a suitable bond between the two partial structures so that they are firmly attached to each other.
The operation in box 604 then attaches any other additional components necessary to complete the product. For example, if the product is implemented as in FIG. 12 or 13, detector 436 or detector 466 must be attached by the operation in box 604. Similarly, if the product is implemented as in FIG. 13, light source 468 must be attached to the product by the operation in box 604. The operation in box 604 can also include any other external electrical, optical, or fluidic connections necessary for operation of the product, or, alternatively, such connections could later be made at the time the product is implanted.
The choice of a detector can be made based on several constraints. For example, if intensity peaks of a small number of modes are photosensed to detect changes in central energy or position, amplitude, contrast, and FWHM, it may be possible to use a respective one-dimensional photosensing array for each optical cavity, with each array including a relatively small number of cells, reducing the electrical power requirement because less power is dissipated in the detector. In general, compactness is promoted by using a photosensing IC, as described in co-pending U.S. patent application Ser. No. 11/702,250, entitled �Photosensing Optical Cavity Output Light� and incorporated by reference herein in its entirety.
The operation in box 606 can be performed at any appropriate time after the product is operable, as suggested by the dashed line from box 604 to box 606, and may not be necessary if self-calibration as described above provides satisfactory results. The operation in box 606 performs calibration, which requires appropriate electrical and optical operations, which may require connections of circuitry. In any case, calibration in box 606 can include obtaining items of data or data structures to be used in obtaining analyte information as described herein, and the data or data structures can be stored in memory 246 as part of calibration data 276 (FIG. 8), or, in appropriate cases, can be embedded in analyte information routine 274 or stored in another appropriate form. In particular, the operation in box 606 can include operations that produce one or more calibration tables or reference curves for the reference fluid, such as under different temperatures or other environmental conditions.
Finally, the operation in box 608 implants the resulting product in a body, such as in a human body, to monitor glucose. If the product is sufficiently small, implantation can be performed simply by pushing the product through the skin into an appropriate part of the body in which the analyte container will be filled with blood, lymph, interstitial fluid, or other bodily fluid.
In general, the operations in any of boxes 600, 602, 604, 606, and 608 can include additional activities. For example, at any appropriate point in production of the product, electrical or optical connections can be made so that signals can be provided as necessary. Similarly, connections can be made at any appropriate time to provide electrical power. Also, it might be possible to precisely tune optical cavity dimensions, such as using techniques as described in co-pending U.S. patent application Ser. No. 11/702,321, entitled �Tuning Optical Cavities� and in co-pending U.S. patent application Ser. No. 11/702,320, entitled �Tuning Optical Cavities�, both of which are incorporated by reference herein in their entireties.
The technique of FIG. 16 could be modified in many ways within the scope of the invention. For example, the operations in boxes 600, 602, and 604 could be combined in any appropriate way to facilitate attachment of components in a desired sequence. Furthermore, the technique of FIG. 16 is extremely general, and could be employed to produce a wide variety of different products that can be implanted within a body to obtain reference-adjusted information about analytes in bodily fluids.
The implementations described above could be applied in many ways, but an especially important area of application is in continuous or frequent monitoring of glucose concentration as is needed for diabetes management and reduction of complications. Fast, precise, and constant or even continuous glucose monitoring would help ensure detection of episodes of hyper- and hypoglycemia. Current techniques, such as finger-sticking to obtain a blood sample, have various difficulties that might be overcome with a compact optical device.
The implementations described above are consistent with a compact, minimally invasive, disposable product that could be implanted to allow optical measurement of glucose concentration in a small volume of bodily fluid. Such a product could be designed to last an appropriate length of time before it must be replaced; durations of at least two weeks are believed to be achievable with low power consumption measures. It is also believed possible to produce such products at a sufficiently low cost to make disposable versions feasible.
In using such a product, a defined characterization volume of the bodily fluid would be positioned within an optical cavity paired with a reference optical cavity. This technique offers the possibility of continuous self-calibration with a reference fluid under the same environmental conditions and enhanced sensitivity and specificity, and reducing or eliminating the effect of tissue and skin perturbations on measurements.
As described above, features of intensity peaks of an optical cavity's modes can provide information about several optical characteristics of glucose, including absorption spectrum, refractive index dispersion, either or both of which can be measured at discrete sampling points of the energy spectrum. Precise information, such as about central energy, amplitude, contrast, and FWHM of an intensity peak, can be obtained for each sampling point with a chip-size detector, as described in co-pending U.S. patent application Ser. No. 11/702,250, entitled �Photosensing Optical Cavity Output Light� and incorporated by reference herein in its entirety. The information could be obtained in digital form, allowing data processing, which can obtain information with adequate sensitivity and specificity with improved signal-to-noise ratio. In addition to self-calibration using the reference fluid as mentioned above, photosensed quantities and sensing results could be adjusted in various other ways, such as with contrast-based adjustment, such as by measuring a peak-to-valley ratio to obtain the finesse, which is a measure of absorption for a given Fabry-Perot etalon; other contrast-based adjustment techniques are described in co-pending U.S. patent application Ser. No. 11/702,249, entitled �Obtaining Information From Optical Cavity Output Light� and incorporated herein by reference in its entirety.
With data processing techniques that provide sufficient sensitivity, concurrently obtaining the absorption spectrum and refractive index dispersion in the near infrared range, at wavelengths between approximately 2.1-2.5 μm, may be sufficient to determine glucose concentration, though the techniques described herein could be used in almost any wavelength range suitable for glucose sensing. Refractive index information contains absorption information from other spectral ranges, in accordance with the Kramers-Kronig relation, and therefore can be used as additional information on glucose concentration in a multiple signal analysis. Multiple signal analysis could be extended by measuring in multiple wavelength ranges, especially in spectral bands that provide key information on glucose level. It may be possible to perform additional characterization techniques using the same implantable product, such as optical polarimetry and fluorescence. Information could also be used from electrical techniques such as conductivity or capacitance measurement.
Some of the implementations described above in relation to FIGS. 1-16 are examples of implantable products that include an optical cavity structure with first and second optical cavity parts. Each part can be operable as an optical cavity, and each can include a container. The first part's container has at least one opening through which bodily fluid can transfer between the container's interior and exterior when the product is implanted in a body. The second part's container is closed and contains a reference fluid.
In specific implementations, each part can operate as a Fabry-Perot cavity, and can be homogeneous or inhomogeneous, possibly with both parts being tunable; each part can provide output light in a set of modes. The product can also include a light source positioned to provide light to both parts, and it can include a photosensing component positioned to receive light from both parts. The product can include circuitry that receives sensing results from the photosensing component and uses the sensing results to obtain information about the bodily fluid, which could, for example, be a glucose solution.
Some of the implementations described above in relation to FIGS. 1-16 also illustrate examples of a system that includes an implantable product as described above and processing circuitry that adjusts photosensed quantities from the first part's output light based on photosensed quantities from the second part's output light to obtain information about the bodily fluid in the first part's container.
In specific implementations, the system also includes a light source as described above, providing input light under control of the processing circuitry, such as in a set of modes. The light source component can be included in the product, as can a photosensing component.
Some of the implementations described in relation to FIGS. 1-16 also illustrate examples of a method of making an implantable product as described above. The method can produce each of the parts to include a respective container as described above.
In specific implementations, two partial optical cavity structures can be produced and then connected to form the optical cavity structure. Also, a photosensing component or a light source component can be connected to the optical cavity structure.
Some of the implementations described in relation to FIGS. 1-16 similarly illustrate examples of a method of using an implantable product as described above. The method can implant the product in a body, operate a light source component to provide input light to both parts, and then operate a photosensing component to photsense the output light from both parts.
In specific implementations, such a method can use the sensing results from the second part to adjust sensing results form the first part.
Some of the implementations described above in relation to FIGS. 1-16 also illustrate examples of implantable products that include an optical cavity structure with first and second parts. Each part includes a container as described above and a light-transmissive region that includes at least part of its container, and a set of reflective surfaces that at least partially bound the light-transmissive region so that the part can operate as an optical cavity. Each part also has one or more light interface surfaces at which light can enter and exit. The structure in turn has at least one aligned light interface surface in which one surface from both parts is aligned; in operation, the aligned surface receives input light that enters both parts through the aligned surface, provides output light from both parts through the aligned surface, or both.
In specific implementations, in addition to features described above, each of the parts can have both an interface surface that receives the input light and also an interface surface that provides the output light. The input interface surfaces can be aligned in a first aligned surface and the output interface surfaces in another.
The implementations in FIGS. 1-16 illustrate various applications of techniques as described above, including implantable products that include optical cavity structures with containers for bodily fluids and reference fluids. The products can be implanted in bodies and used to obtain and adjust information about an analyte such as glucose in bodily fluid, such as about its refractive index and absorption coefficient. The techniques could be extended to obtain information about polarization and fluorescence, allowing multiple component analysis.
Techniques that use implantable products to obtain information about analytes, as exemplified by the implementations in FIGS. 1-16, can be applied in various diagnostic and monitoring applications, in which a compact, inexpensive, disposable product would be highly desirable. Information about refractive index and absorption, for example, could be used to identify presence or quantity of glucose or another analyte indicating a disease condition. For example, the techniques could be used to measure absorption coefficient and derivative to detect glucose.
The exemplary implementations described above allow compact, inexpensive implantable products for use in operations such as measuring glucose and other analytes. In general, the techniques can be implemented using existing sensors and photosensors and existing light sources.
The exemplary implementations described above employ optical cavities with specific parameters and modes, but a wide variety of cavities could be used. Cavities with widths in the range from a few microns to hundreds of microns are feasible, and photon energies ranging from the ultraviolet up to the far infrared could be sampled.
Components of exemplary implementations as described above could have various shapes, dimensions, or other numerical or qualitative characteristics other than those illustrated and described above. For example, optical cavities could have any suitable dimensions.
Some of the above exemplary implementations involve specific materials, such as in optical cavity structures and photosensing components, but the invention could be implemented with a wide variety of materials and with layered structures with various combinations of sublayers. In particular, photosensor arrays for a desired speed, sensitivity and wavelength range could have any suitable material, such as silicon, germanium, indium-gallium-arsenide, gallium arsenide, gallium nitride, or lead sulphide, and could be produced with any appropriate kind of devices, including, for example, photodiodes, avalanche photodiodes, p-i-n diodes, photoconductors, and so forth, with any appropriate technique for sensing and reading out information whether based on CCD, CMOS, or other techniques. Various commercially available detector arrays have pixel densities as high as ten megapixels, and some high density ICs have become relatively inexpensive.
Similarly, optical cavity structures could be fabricated with any appropriate techniques, including thin film technology such as sputtering, e-beam or thermal evaporation with or without plasma assistance, epitaxial growth, MBE, MOCVD, and so forth. To produce Bragg mirrors, appropriate pairs of materials with low absorption coefficients and large difference in refractive indices could be chosen, bearing in mind the photon energies of interest; exemplary materials include SiO2/TiO2, SiO2/Ta2O5, GaAs/AlAs, and GaAs/AlGaAs. Thicknesses of layer in optical cavity structures may vary from 30 nm up to a few hundred nanometers.
Some of the above exemplary implementations could involve particular types of optical cavity structures, such as Bragg mirrors and paired distributed Bragg reflectors separated by a Fabry-Perot cavity, but, more generally, any appropriate optical cavity structure could be used. Various techniques could be used to produce optical cavity structures in addition to those described above.
The exemplary implementation in FIGS. 8 and 10 employs a CPU, which could be a microprocessor or any other appropriate component. Furthermore, as noted above, adjustment, combining, and other operations on photosensed quantities could be done either digitally or with analog signals, and could be done either on the same IC as a photosensor array, on other components, or on a combination of the two, with any appropriate combination of software or hardware.
The above exemplary implementations generally involve production and/or use of ICs and other photosensing components, optical cavities, light sources, transmission structures, processing circuitry, and control circuitry following particular operations, but different operations could be performed, the order of the operations could be modified, and additional operations could be added within the scope of the invention. For example, readout of adjusted or unadjusted photosensed quantities from an IC could be performed serially or in parallel, and could be performed cell-by-cell or in a streaming operation.
Citas de patentes Patente citada Fecha de presentaci�n Fecha de publicaci�n Solicitante T�tuloUS39155734 Feb 197428 Oct 1975Hewlett-Packard GmbhVariable-frequency interferometer resonance filterUS514449814 Feb 19901 Sep 1992Hewlett-Packard CompanyVariable wavelength light filter and sensor systemUS515158512 Ago 199129 Sep 1992Hughes Danbury Optical Systems, Inc.Coherent radiation detectorUS524361421 Nov 19917 Sep 1993Mitsubishi Denki Kabushiki KaishaWavelength stabilizer for narrow bandwidth laserUS53942446 Oct 199228 Feb 1995Excel Precision Inc.Ambient air refracture index measuring deviceUS54145082 Mar 19939 May 1995Hitachi, Ltd.Optical cell and optical detection systems light absorptionUS546147710 Mar 199524 Oct 1995Physical Sciences, Inc.Method and apparatus for imagingUS578450726 Abr 199421 Jul 1998Holm-Kennedy; James W.Integrated optical wavelength discrimination devices and methods for fabricating sameUS579348513 Ene 199711 Ago 1998Sandia CorporationResonant-cavity apparatus for cytometry or particle analysisUS594567628 Ene 199831 Ago 1999Instrumentation Metrics, Inc.Method and apparatus for multi-spectral analysis in noninvasive NIR spectroscopyUS60405782 Feb 199621 Mar 2000Instrumentation Metrics, Inc.Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopyUS60497273 Abr 199811 Abr 2000Animas CorporationImplantable sensor and system for in vivo measurement and control of fluid constituent levelsUS610846319 Mar 199722 Ago 2000University Of Utah Research FoundationLens and associatable flow cellUS61225368 Jul 199619 Sep 2000Animas CorporationImplantable sensor and system for measurement and control of blood constituent levelsUS618759223 Dic 199813 Feb 2001Sandia CorporationMethod for determining properties of red blood cellsUS621602222 Jun 200010 Abr 2001Biosafe Laboratories, Inc.Implantable optical measurement device and method for using sameUS628550427 Abr 20004 Sep 2001Jds Uniphase Inc.Variable optical filterUS629513022 Dic 199925 Sep 2001Xerox CorporationStructure and method for a microelectromechanically tunable fabry-perot cavity spectrophotometerUS642902222 Feb 20006 Ago 2002Csem Centre Suisse D'Electronique Et De Microtechnique SaIntegrated-optical sensor and method for integrated-optically sensing a substanceUS643839728 Oct 199920 Ago 2002Bosquet Gerald G.Method and apparatus for analyte detection using intradermally implanted skin portUS648395924 Feb 199919 Nov 2002The University Of Manchester Institute Of Science And TechnologyWaveguide structuresUS649003411 Nov 19973 Dic 2002Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.Micromechanical transmission measuring cellUS656197811 Feb 200013 May 2003Cygnus, Inc.Devices and methods for frequent measurement of an analyte present in a biological systemUS65805072 Mar 200117 Jun 2003Sd Acquisition Inc.Single source, single detector chip, multiple-longitudinal channel electromagnetic radiation absorbance and fluorescence monitoring systemUS659746119 Ene 200122 Jul 2003Parvenu, Inc.Tunable fabry-perot interferometer using entropic materialsUS66396799 Ene 200128 Oct 2003Telefonaktiebolaget L M Ericsson (Publ)Integrated wavelength monitorUS669415811 Abr 200117 Feb 2004Motorola, Inc.System using a portable detection device for detection of an analyte through body tissueUS68678688 Ene 200315 Mar 2005Avanex CorporationMethod and apparatus for tunable interferometer utilizing variable air densityUS69344354 Oct 200223 Ago 2005ARET� ASSOCIATESMicrofluidic pump system for chemical or biological agentsUS695260316 Mar 20014 Oct 2005Roche Diagnostics Operations, Inc.Subcutaneous analyte sensorUS698317611 Abr 20013 Ene 2006Rio Grande Medical Technologies, Inc.Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopyUS701163021 Jun 200214 Mar 2006Animas Technologies, LlcMethods for computing rolling analyte measurement values, microprocessors comprising programming to control performance of the methods, and analyte monitoring devices employing the methodsUS701269612 Jul 200114 Mar 2006Macquarie Research Ltd.Optical heterodyne detection in optical cavity ringdown spectroscopyUS70242368 Abr 20044 Abr 2006Animas Technologies LlcFormulation and manipulation of databases of analyte and associated valuesUS706483611 Dic 200320 Jun 2006The Board Of Trustees Of The Leland Stanford Junior UniversityBrewster's angle flow cell for cavity ring-down spectroscopyUS713032116 Abr 200431 Oct 2006Coherent, Inc.Intracavity frequency-tripled CW laser with traveling-wave ring-resonatorUS714939615 Jun 200412 Dic 2006Brigham Young UniversityApparatus for optical measurements on low-index non-solid materials based on arrow waveguidesUS725985616 Feb 200521 Ago 2007Picarro, Inc.Method for the precise measurement of the wavelength of lightUS729182422 Dic 20056 Nov 2007Palo Alto Research Center IncorporatedPhotosensing throughout energy range and in subrangesUS731015323 Ago 200418 Dic 2007Palo Alto Research Center, IncorporatedUsing position-sensitive detectors for wavelength determinationUS731566722 Dic 20051 Ene 2008Palo Alto Research Center IncorporatedPropagating light to be sensedUS735847622 Dic 200515 Abr 2008Palo Alto Research Center IncorporatedSensing photons from objects in channelsUS739151723 Dic 200424 Jun 2008Commissariat A L'Energie AtomiqueMethod and device for measuring the absorption or light diffusion of biological elementsUS743355222 Dic 20057 Oct 2008Palo Alto Research Center IncorporatedObtaining analyte informationUS74713995 Feb 200730 Dic 2008Palo Alto Research Center IncorporatedPhotosensing optical cavity output lightUS75021235 Feb 200710 Mar 2009Palo Alto Research Center IncorporatedObtaining information from optical cavity output lightUS75455135 Feb 20079 Jun 2009Palo Alto Research Center IncorporatedEncoding optical cavity output lightUS754790422 Dic 200516 Jun 2009Palo Alto Research Center IncorporatedSensing photon energies emanating from channels or moving objectsUS75546735 Feb 200730 Jun 2009Palo Alto Research Center IncorporatedObtaining information about analytes using optical cavity output lightUS76336295 Feb 200715 Dic 2009Palo Alto Research Center IncorporatedTuning optical cavitiesUS2003013767214 Ene 200324 Jul 2003Gigaphoton, Inc.Wavelength detecting apparatus, laser apparatus, and wavelength detecting methodUS2003018971112 Jul 20019 Oct 2003Macquarie Research Ltd.Optical heterodyne detection in optical cavity ringdown spectroscopyUS200301913774 Abr 20029 Oct 2003Inlight Solutions, Inc.Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyteUS2003023592423 Ene 200325 Dic 2003California Institute Of TechnologyOptoelectronic and microfluidic integration for miniaturized spectroscopic devicesUS200401757345 Dic 20039 Sep 2004Febit Ferrarius Biotechnology GmbhSupport for analyte determination methods and method for producing the supportUS200500996247 Nov 200312 May 2005Carefusion 303, Inc.Fluid verification system and method for infusionsUS2005012487319 Ene 20059 Jun 2005Dexcom, Inc.Device and method for determining analyte levelsUS200502496054 Oct 200210 Nov 2005Bank Of The WestCirculating microfluidic pump system for chemical or biological agentsUS2006003900923 Ago 200423 Feb 2006Palo Alto Research Center IncorporatedChip-size wavelength detectorUS200601215558 Dic 20048 Jun 2006Palo Alto Research Center IncorporatedBio-enrichment device to enhance sample collection and detectionUS2006018265919 Mar 200417 Ago 2006The Trustees Of Boston UniversityResonant cavity biosensorUS2006019355016 Dic 200531 Ago 2006Wawro Debra DMethods for using resonant waveguide-grating filters and sensorsUS200700093808 Jul 200511 Ene 2007Sru Biosystems, Inc.Photonic crystal biosensor structure and fabrication methodUS200700703476 Jun 200629 Mar 2007California Institute Of TechnologyMethod and apparatus for CMOS imagers and spectroscopyUS200700762104 Dic 20065 Abr 2007Palo Alto Research Center IncorporatedPosition-based response to lightUS2007014718922 Dic 200528 Jun 2007Palo Alto Research Center IncorporatedSensing photon energies of optical signalsUS2007014772622 Dic 200528 Jun 2007Palo Alto Research Center IncorporatedTransmitting light with photon energy informationUS2007014876022 Dic 200528 Jun 2007Palo Alto Research Center IncorporatedObtaining analyte informationUS2008001309217 May 200717 Ene 2008California Institute Of TechnologyFluorescence detector, filter device and related methodsUS200801864885 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedDistinguishing objectsUS200801864925 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedEncoding optical cavity output lightUS200801864945 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedContaining analyte in optical cavity structuresUS200801865005 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedObtaining information from optical cavity output lightUS200801865035 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedPhotosensing optical cavity output lightUS200801865045 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedMoving analytes and photosensorsUS200801865085 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedTuning optical cavitiesUS200801870115 Feb 20077 Ago 2008Palo Alto Research Center IncorporatedTuning optical cavitiesUS2009015691717 Dic 200718 Jun 2009Palo Alto Research Center IncorporatedControlling Transfer of Objects Affecting Optical CharacteristicsUS2009022018923 Mar 20093 Sep 2009Palo Alto Research Center IncorporatedTransmitting Light with Lateral VariationDE19540456A1 T�tulo no disponibleWO2002001202A125 May 20013 Ene 2002Barnikol, WolfgangDevice for combined and simultaneous use of several measuring methods for analysing components of a liquid mixture of several substancesWO2006133360A27 Jun 200614 Dic 2006Adams, MarkA method and apparatus for cmos imagers and spectroscopyWO2009015723A17 Jun 20085 Feb 2009Freitag, Hans-JoachimSubstance concentration sensor and production method thereforOtras citasReferencia1Amendment After Final Rejection in U.S. Appl. No. 11/702,328, submitted Nov. 12, 2009, 22 pages.2Amendment in EPO Application No. 08171499.0-2319/2072006, submitted Jun. 21, 2010, 32 pages.3Amendment in U.S. Appl. No. 11/702,249, submitted Nov. 7, 2008, 30 pages.4Amendment in U.S. Appl. No. 11/702,320, submitted Apr. 8, 2010, 26 pages.5Amendment in U.S. Appl. No. 11/702,320, submitted May 7, 2009, 29 pages.6Amendment in U.S. Appl. No. 11/702,320, submitted Nov. 3, 2009, 24 pages.7Amendment in U.S. Appl. No. 11/702,321, submitted May 8, 2009, 21 pages.8Amendment in U.S. Appl. No. 11/702,325, submitted Mar. 17, 2010, 26 pages.9Amendment in U.S. Appl. No. 11/702,325, submitted Nov. 17, 2008, 38 pages.10Amendment in U.S. Appl. No. 11/702,325, submitted Nov. 2, 2009, 25 pages.11Amendment in U.S. Appl. No. 11/702,328, submitted Apr. 28, 2010, 21 pages.12Amendment in U.S. Appl. No. 11/702,470, submitted Jan. 30, 2009, 22 pages.13Amendment in U.S. Appl. No. 11/702,470, submitted Jul. 25, 2008, 21 pages.14Amendment with Information Disclosure in U.S. Appl. No. 11/702,363, submitted Dec. 4, 2008, 34 pages.15Amendment with Request for Continued Examination in U.S. Appl. No. 11/702,328, submitted Dec. 29, 2009, 24 pages.16Amendment with Terminal Disclaimer in U.S. Appl. No. 11/702,325, submitted Jan. 18, 2010, 18 pages.17An Office communication in U.S. Appl. No. 11/702,320, mailed Apr. 15, 2010, 3 pages.18An Office communication in U.S. Appl. No. 11/702,325, mailed Mar. 24, 2010, 3 pages.19An Office communication in U.S. Appl. No. 11/702,328, mailed May 17, 2010, 9 pages.20Communication from European Patent Office, including extended European search report with Partial European Search Report, Incomplete Search Sheet C, and Annex, and European search opinion for counterpart EPO Application No. 08151021.6, dated Jul. 10, 2008, 10 pages.21European Patent Office communication in EPO Patent Application No. 08171499.0-2319/2072006, mailed Feb. 5, 2010, 1 page.22Kondziela, J., "Accurately Measure Laser Spectral Chracteristics," www.exfo.com, 2006, 5 pages.23McNichols, R.J., Cote, G.L., "Optical glucose sensing in biological fluids: an overview," Journal of Biomedical Optics, Jan. 2000, vol. 5, No. 1, pp. 5-16.24Notice of Allowance and Fee(s) Due in U.S. Appl. No. 11/702,249, mailed Nov. 28, 2008, 9 pages.25Notice of Allowance and Fee(s) Due in U.S. Appl. No. 11/702,250, mailed Jun. 18, 2008, 11 pages.26Notice of Allowance and Fee(s) Due in U.S. Appl. No. 11/702,321, mailed Aug. 11, 2009, 20 pages.27Notice of Allowance and Fee(s) Due in U.S. Appl. No. 11/702,363, mailed Mar. 23, 2009, 12 pages.28Notice of Allowance and Fee(s) Due in U.S. Appl. No. 11/702,470, mailed Apr. 24, 2009, 15 pages.29Office communication in EPO Application No. 08150964.8-1524, mailed May 7, 2010, 6 pages.30Office communication in U.S. Appl. No. 11/702,249, mailed Aug. 7, 2009, 16 pages.31Office communication in U.S. Appl. No. 11/702,320, mailed Aug. 12, 2009, 9 pages.32Office communication in U.S. Appl. No. 11/702,320, mailed Feb. 24, 2010, 21 pages.33Office communication in U.S. Appl. No. 11/702,320, mailed Jun. 4, 2010, 29 pages.34Office communication in U.S. Appl. No. 11/702,321, mailed Feb. 20, 2009, 19 pages.35Office communication in U.S. Appl. No. 11/702,325, mailed Aug. 15, 2008, 14 pages.36Office communication in U.S. Appl. No. 11/702,325, mailed Aug. 28, 2009, 13 pages.37Office communication in U.S. Appl. No. 11/702,325, mailed Feb. 10, 2009, 8 pages.38Office communication in U.S. Appl. No. 11/702,325, mailed Feb. 4, 2010, 19 pages.39Office communication in U.S. Appl. No. 11/702,325, mailed May 27, 2010, 23 pages.40Office communication in U.S. Appl. No. 11/702,328, mailed Jan. 28, 2010, 13 pages.41Office communication in U.S. Appl. No. 11/702,328, mailed Jul. 22, 2010, 8 pages.42Office communication in U.S. Appl. No. 11/702,328, mailed May 27, 2009, 28 pages.43Office communication in U.S. Appl. No. 11/702,328, mailed Oct. 5, 2009, 23 pages.44Office communication in U.S. Appl. No. 11/702,363, mailed Sep. 4, 2008, 29 pages.45Office communication in U.S. Appl. No. 11/702,470, mailed Apr. 25, 2008, 22 pages.46Office communication in U.S. Appl. No. 11/702,470, mailed Oct. 31, 2008, 22 pages.47Response with Terminal Disclaimer in U.S. Appl. No. 11/702,325, submitted May 5, 2009, 5 pages.48Rule 312 Amendment in U.S. Appl. No. 11/702,321, submitted Oct. 27, 2009, 16 pages.49Submission to European Patent Office in counterpart EPO Application No. 08151021.6, dated Sep. 22, 2009, 14 pages.50Vogel, W., Berroth, M., "Tuneable liquid crystal Fabry-Perot filters", Institute for Electrical and Optical Communication Engineering, University of Stuttgart, 2002, 10 pages. Citada por Patente citante Fecha de presentaci�n Fecha de publicaci�n Solicitante T�tuloUS832098317 Dic 200727 Nov 2012Palo Alto Research Center IncorporatedControlling transfer of objects affecting optical characteristicsUS832456026 Feb 20084 Dic 2012Koninklijke Philipe Electronics N.V.Optical detector deviceUS2009015691717 Dic 200718 Jun 2009Palo Alto Research Center IncorporatedControlling Transfer of Objects Affecting Optical CharacteristicsUS2010003255126 Feb 200811 Feb 2010Koninklijke Philips Electronics N.V.Optical detector deviceGirarImagen originalP�gina principal de Google - Sitemap - Descargas masivas de USPTO - Pol�tica de privacidad - Condiciones de servicio - Acerca de Google Patentes - Danos tu opini�nDatos proporcionados por IFI CLAIMS Patent Services©2012 Google